Literature DB >> 3876382

Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).

A D Procopio, P Allavena, J R Ortaldo.   

Abstract

Highly purified human large granular (LGL), depleted of any detectable contaminant T and B cells or monocytes, were found to be potent producers in vitro of a soluble B cell growth factor (BCGF) able to sustain proliferation of B cells activated by anti-mu. Activation by lectins (phytohemagglutinin, PHA, concanavalin A, Con A; and pokeweed mitogen, PWM) was required to induce the production of high levels of this BCGF from cultured LGL. Production of BCGF was also detected after the binding of LGL with natural killer (NK)-sensitive (K562) but not with NK-resistant (RL male 1) target cells. In contrast to T cells, LGL did not need the additional presence of accessory cells to reach optimal production of BCGF by 72 hr of culture. The subpopulation of LGL responsible for the production of BCGF had phenotypic characteristics associated with NK cells (3G8+, HNK1+/OKT11+, DR-, OKT3-, Leu-M1-), and separated cells with these markers exerted high levels of NK activity. Selective production of BCGF also was obtained from cytotoxic clones derived from LGL. A partial characterization of the LGL-derived BCGF was performed by gel filtration. BCGF activity was detected in fractions with estimated m.w. of 20,000 and 45,000. The LGL-derived BCGF activity was resistant to reduction with 2-mercaptoethanol and was stable at -20 degrees C for months. Conversely, heating (56 degrees C for 1 hr) or digestion with trypsin greatly reduced the LGL-derived BCGF activity. These findings strongly suggest that LGL including those with NK activity can play an important positive role in the early events of the B cell-mediated immune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Suppression of in vitro immunoglobulin synthesis by CD16(Leu11a)+ CD56 (NKH1,Leu19)+non-T lineage NK cells; lack of suppression of cells from immunodeficient patients.

Authors:  T Morio; S Nonoyama; J Yata
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Effects of interleukin-2 and interleukin-2-activated cells on in vitro myelopoiesis.

Authors:  M Clerigue; P Pisa; L Tsai; M Hanson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis.

Authors:  M A Rodriguez; I Blanca; M L Baroja; S Arama; M Leon-Ponte; I Abadi; N E Bianco
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

4.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.

Authors:  H Kimata; E H Sherr; A Saxon
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

6.  Abnormal NK cell lymphocytosis detected after splenectomy: association with repeated infections, relapsing neutropenia, and persistent polyclonal B-cell proliferation.

Authors:  Elisa Granjo; Margarida Lima; Manuela Fraga; Filipe Santos; Conceição Magalhães; Maria Luís Queirós; Ilidia Moreira; Sandra Rocha; Alice Santos Silva; Irene Rebelo; Alexandre Quintanilha; Maria Letícia Ribeiro; Jorge Candeias; Alberto Orfão
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

7.  NK cells blur the frontier between innate and acquired immunity.

Authors:  Giuseppe Terrazzano; Ennio Carbone
Journal:  Front Immunol       Date:  2013-01-02       Impact factor: 7.561

8.  Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4.

Authors:  J Lorenzen; C E Lewis; D McCracken; E Horak; M Greenall; J O McGee
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.